Showing results (1261-1270 of 1,622) with videos related to

Sort By:
Pageof 163
The New England Journal of Medicine|June 4, 2010
Pallidal versus subthalamic deep-brain stimulation for Parkinson's diseaseKenneth A Follett, Frances M Weaver, Matthew Stern, et al.
The Lancet. Neurology|October 26, 2010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialWilliam J Marks, Raymond T Bartus, Joao Siffert, et al.
JMIR Mental Health|August 12, 2021
Toward a Mobile Platform for Real-world Digital Measurement of Depression: User-Centered Design, Data Quality, and Behavioral and Clinical ModelingStefanie Nickels, Matthew D Edwards, Sarah F Poole, et al.
Epilepsia|April 23, 2004
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy SocietyJacqueline A French, Andres M Kanner, Jocelyn Bautista, et al.
Cardiology in the Young|September 29, 2025
Breastfeeding infants with CHD: an evidence summary and recommendations from the Cardiac Newborn Neuroprotective Network, a special interest group of the Cardiac Neurodevelopmental Outcome CollaborativeKristin M Elgersma, Jessica A Davis, Shripriya Mohan-ONeill, et al.
Science Advances|October 3, 2025
Enhanced spectral purity of WSe2 quantum emitters via conformal organic adlayersRiddhi Ananth, M Iqbal Bakti Utama, David D Xu, et al.
Epilepsia|April 23, 2004
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy SocietyJacqueline A French, Andres M Kanner, Jocelyn Bautista, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Neurology|June 23, 2012
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomesFrances M Weaver, Kenneth A Follett, Matthew Stern, et al.
Pageof 163